# Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment

> **NCT01123421** · — · COMPLETED · sponsor: **Artann Laboratories** · enrollment: 113 (actual)

## Conditions studied

- Osteoporosis
- Fracture
- Aging

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01123421
- **Lead sponsor:** Artann Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-04
- **Final completion:** 2012-02
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2012-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01123421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01123421, "Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01123421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*